Font Size
A
A
A

Women's Health Initiative (WHI): Risks and Benefits of Hormone Replacement Therapy (HRT) and Estrogen Replacement Therapy (ERT)


Women's Health Initiative (WHI): Risks and Benefits of Hormone Replacement Therapy (HRT) and Estrogen Replacement Therapy (ERT)

Hormone replacement therapy (HRT) was part of a large set of clinical trials called the Women's Health Initiative (WHI). The HRT portion of the study was ended 3 years early because of a small but unacceptable increase in the rate of breast cancer among the women taking a combination of 0.625 mg of estrogen plus 2.5 mg of progestin daily. As the WHI data has been analyzed, risks of blood clots, heart disease, ovarian cancer, and dementia have also been identified. Experts do not yet know whether lower-dose, shorter-term HRT reduces or eliminates these risks.

The results of the WHI study can be hard to understand. Some of the women in this study took HRT (estrogen and progestin) and some took ERT (estrogen only). Each group was compared to women who took a placebo.

The study found that in a small number of women, using HRT increased the risk of:1

  • Breast cancer.
  • Stroke.
  • Heart disease.
  • Blood clots.
  • Dementia in women 65 and older.

The WHI study also found that HRT may reduce the risk of:1

  • Colorectal cancer.
  • The number of broken bones in women who are past menopause.

The WHI study also found that in a small number of women, using ERT increased the risk of:1

  • Stroke.
  • Blood clots.

The WHI study found that women who took ERT had fewer broken bones than women who did not take ERT. The study also found that women who took ERT did not have an increased risk for heart disease or for colorectal cancer.1 Follow-up studies have shown that a woman's age when she started taking ERT affects whether she has an increased risk for heart problems and for colorectal cancer. The reduced risk for hip fracture did not continue after ERT was stopped.2

The link between ERT and breast cancer is unclear. One study showed that the risk for breast cancer was lower for women who took ERT even after they stopped taking it.2

It is important to remember that average risks from HRT and ERT are low among the general population of women. But your personal risk that hormone therapy may lead to certain health problems, such as heart disease or breast cancer, may be lower or higher depending on your risk factors for those health problems.

For more information about the Women's Health Initiative study, see the National Institutes of Health website about the WHI at www.nhlbi.nih.gov/whi.

References

Citations

  1. National Institutes of Health (2009). Women's Health Initiative. Available online: http://www.nhlbi.nih.gov/whi.

  2. LaCroix AZ, et al. (2011). Health Outcomes After Stopping Conjugated Estrogens Among Postmenopausal Women With Prior Hysterectomy. JAMA, 305(13): 1305-1314.

Credits

ByHealthwise Staff
Primary Medical ReviewerKathleen Romito, MD - Family Medicine
Specialist Medical ReviewerCarla J. Herman, MD, MPH - Geriatric Medicine
Last RevisedMay 2, 2011

eMedicineHealth Medical Reference from Healthwise

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.





Medical Dictionary